Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dog study reveals information about human brain tumours
Boxer
Brachycephalic breeds like boxers and bulldogs are at particular risk of developing glioma.

Genome responsible for rare Glioma discovered

Researchers have located genomes in a study into closely linked dog and human brain tumours.

Published in the journal PLOS Genetics,  scientists from Uppsala University and Swedish University of Agricultural Sciences, analysed genes in different dog breeds linked to the development of the rarely curable glioma.

Brachycephalic breeds like boxers and bulldogs are at particular risk of developing glioma. By
identifying a genomic region shared by the breeds, researchers determined that genomic links were likely.

"In our study we hypothesized that since the brachycephalic dog breeds with elevated risk are closely related we would be able to identify a genomic region shared by those breeds," says Katarina Truvé, former doctoral student at the Swedish University of Agricultural Sciences.

She contiued: "The same risk factors for glioma could also be present in other breeds and the way to identify the genomic region would be to compare genetic markers from dogs diagnosed with glioma from several breeds to healthy controls."

Further genetic analyses were performed using 25 different dog breeds and the researchers could identify an area in the genome that differed between diseased and healthy dogs.

Within this genome, three genes were identified as associated with glioma development, which humans also have.  

Karin Forsberg Nilsson, Professor at the Department of Immunology, Genetics and Pathology and Science for Life Laboratory, said: "These results indicate that further investigations of the role of these three genes in glioma development would be of interest, with potential benefit to both dog and human."

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.